Shuwen Biotech and Hengrui Medicine Enter into Strategic Partnership
News Jul 31, 2015
Shuwen Biotech Co. Ltd. and Jiangsu Hengrui Medicine Co., Ltd. have announced that they have entered into a collaboration agreement for companion diagnostics development.
Under the agreement, Shuwen Biotech will develop companion diagnostic assays and kits for an unidentified anticancer drug candidate Hengrui is developing.
Hengrui will also entrust Shuwen to screen patients at Shuwen’s diagnostic reference labs using the diagnostic assays for Hengrui’s clinical trials. Shuwen will manufacture and market the diagnostic kit upon regulatory approval.
“We are very pleased to have reached this agreement with Shuwen Biotech. Companion diagnostics is an increasingly important component of our drug development. Shuwen is an emerging leader in personalized cancer diagnostics. Shuwen’s capabilities in both IVD kits and reference laboratory testing make it an ideal partner in companion diagnostics for our innovative drug development,” commented Dr. Lianshan Zhang, President of Global R&D at Hengrui.
“Hengrui Medicine is a leader in targeted therapies for cancer with a full pipeline of innovative drugs in development,” stated Jay Z. Zhang, Chairman and CEO of Shuwen Biotech. “This partnership is testimony to the expertise and full capabilities in companion diagnostics we can provide in development, manufacturing, marketing and testing services to our partners and eventually physicians and patients.”
High Fruit and Veg Consumption May Reduce Breast Cancer RiskNews
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.READ MORE
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE
Why Might Super-Tasters be at Higher Cancer Risk?News
High bitter-taste sensitivity is associated with a significantly increased risk of cancer in older British women, according to researchers who conducted a unique study of 5,500 women whose diet, lifestyle and health has been tracked for about 20 years.READ MORE